Raymond James Downgrades Fusion Pharmaceuticals (FUSN) to Market Perform

March 19, 2024 10:05 AM

Raymond James analyst Rahul Sarugaser downgraded Fusion Pharmaceuticals (NASDAQ: FUSN) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found